Table 5:
Anticipatory prescription at end-of-life.[19]
| Symptom anticipated | Treatment plan |
|---|---|
| Pain | Inj. morphine 1–2 mg IV/SC sos or q4h |
| Breathlessness | Inj. morphine 1–2 mg IV/SC sos or q4h |
| Distress/agitation | Inj. midazolam 1–2 mg IV/SC sos or q4h |
| Delirium | Inj. haloperidol 1–2 mg IV/SC sos or q4h |
| Delirium with severe agitation | Inj. haloperidol 1–2 mg IV/SC + |
| Inj. midazolam 1–2 mg IV/SC sos or q4h | |
| Respiratory secretions | Inj. glycopyrrolate 0.2 mg IV/SC sos or q4h |
| Nausea and vomiting | Inj. metoclopramide 20 mg IV/SC sos or q4h |